SCHEDULE 13D 8-26-16

Company

Protagonist Therapeutics, Inc

Filed

August 26, 2016

Accession Number

0001596770-16-000144

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →